Market openNon-fractional

Liquidia/LQDA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Liquidia

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Ticker

LQDA

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Morrisville, United States

Employees

145

Liquidia Metrics

BasicAdvanced
$914M
Market cap
-
P/E ratio
-$1.59
EPS
0.25
Beta
-
Dividend rate
$914M
0.25
7.66
7.317
95.318
101.54
-12.11%
-35.64%
-128.27%
50.694
10.63
11.62
-11.643
-5.72%
176.98%
61.03%
3.46%

What the Analysts think about Liquidia

Analyst Ratings

Majority rating from 7 analysts.
Buy

Liquidia Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,410.34% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.9M
-35.56%
Net income
-$41M
49.27%
Profit margin
-1,410.34%
131.63%

Liquidia Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 69.99%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.36
-$0.24
-$0.42
-$0.54
-
Expected
-$0.16
-$0.21
-$0.24
-$0.32
-$0.34
Surprise
120.47%
12.07%
78.61%
69.99%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Liquidia stock?

Liquidia (LQDA) has a market cap of $914M as of July 05, 2024.

What is the P/E ratio for Liquidia stock?

The price to earnings (P/E) ratio for Liquidia (LQDA) stock is 0 as of July 05, 2024.

Does Liquidia stock pay dividends?

No, Liquidia (LQDA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Liquidia dividend payment date?

Liquidia (LQDA) stock does not pay dividends to its shareholders.

What is the beta indicator for Liquidia?

Liquidia (LQDA) has a beta rating of 0.25. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Liquidia stock

Buy or sell Liquidia stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing